Metformin may curb dementia risk in diabetes patients

07/16/2013 | PhysiciansBriefing.com

A study presented at the Alzheimer's Association International Conference found type 2 diabetes patients treated with metformin had a five-year reduced risk of dementia compared with those on other treatments such as sulfonylureas, thiazolidinediones and insulin. "These results are preliminary evidence that benefits of insulin sensitizers may extend beyond glycemic control to neurocognitive health," researchers wrote.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX